Veea Inc. shares surged 149.34% following the announcement of a potential business combination with NovaGen Group B.V. The deal aims to create NovaGen Health Networks, merging Veea's AI edge-computing tech with NovaGen's regenerative medicine. GeoNova Capital plans a $10 million investment, valuing the combined company around $750 million. This surge stands out amid a broader market downturn, highlighting investor optimism about the new venture. Other stocks like Horizon Quantum and Radiant Logistics also rose, while inverse ETFs gained due to declines in their underlying stocks.
Veea Inc. shares surged 149.34% following a business combination announcement, providing notable market context. For readers following the U.S. technology sector, here is Pluang's market snapshot as of Sep 16, 2026 04:03 WIB: out of 150 priced technology stocks, 66 rose and 82 fell. Notable movers include APPN (Appian Corp) with a 9.84% increase and WIX (Wix.Com Ltd) up 9.04%, while COIN (Coinbase Global, Inc.) declined 10.33%.
Evolution Petroleum reported a fiscal Q4 adjusted loss of $0.02 per share, missing the $0.01 estimate, but revenue rose 15% to $24.21 million, beating expectations. GAAP net income was $4.61 million, up from $3.41 million a year earlier, helped by un...
Shares of Future FinTech Group (FTFT) dropped 28.61% after reversing previous gains, following a recent reverse stock split. Swarmer (SWMR) declined 28.36% as its post-IPO lock-up period expired, increasing potential share supply. Enova International...
Tigress Financial upgraded Intel's price target from $118 to $145, maintaining a "Buy" rating due to strong performance in Intel's Data Center and AI division, which saw a 59% revenue increase to $6.3 billion in Q2. The upcoming IPO of Altera, where ...
Uber Technologies reported a 25% year-over-year increase in gross bookings to $53.7 billion in Q1 2026, driven by growth in ride-hailing, delivery, grocery, retail, and membership services. CEO Dara Khosrowshahi's recent purchase of 141,000 shares wo...
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
